The effect of tamoxifen on established human colorectal cancer cell lines in vitro

Anticancer Research

Volumn 16, Issue 6 B, 1996, Pages 3767-3772

  Ziv, Yehiel ^a,c   Gupta, Manjula K ^a   Milsom, Jeffrey W ^b   Vladisavljevic, Alex ^b   Kitago, Kuniaki ^c   Fazio, Victor W ^b  

^a Clinical Pathology   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Colon cancer; In vitro; Rectal cancer; Tamoxifen

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; ESTROGEN RECEPTOR; TAMOXIFEN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG MECHANISM; ENZYME IMMUNOASSAY; FETAL CALF SERUM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECTUM CANCER;

ANTINEOPLASTIC AGENTS, HORMONAL; CELL DIVISION; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; ESTROGEN ANTAGONISTS; HUMANS; RECTAL NEOPLASMS; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0030513618     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Boring CC, Squires TS, long T: Cancer statistics. Ca, 43: 7-26, 1993.
2. Wolmark N, Fisher B, Rockette H. Redmond C, Wickerham DL, Fisher ER, Jones J, Glass A, Lerner H, Lawrence W: Postoperative adjuvant chemotherapy or BCG for colon cancer. J Natl Cancer Inst 80: 30-36, 1988.
3. Lynch HT, Lynch PM, Keathley J: Epidemiology of colon cancer. In: Lynch PM, Lynch HT, editors. Colon cancer genetics, pp 25-48. New York: Von Nortrand Reinhold Company. 1985.
4. Tutton PJM, Barkla DHB: Steroid hormones as regulators of the proliferative activity of normal and neoplastic intestinal epithelial cells. Anticancer Res 8: 451-456, 1988.
5. Morris DL, Watson SA, Durrant LG, Harrison JD: Hormonal control of gastric and colorectal cancer in man. Gut 30: 425-429, 1989.
6. Baum M, Ziv Y, Colletta A: Prospects for the chemoprevention of breast cancer. British Med Bull 47: 493-503, 1991.
7. Landegren U: Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J of Immun Methods 67: 379-388, 1984.
8. Thorpe SM: Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method. Cancer Res 47: 6572-6575, 1987.
9. O'Brian CA, Liskamp RM, Solomon DH, Weinstein B: Inhibition of protein kinase C by tamoxifen. Cancer Res 45: 2462-2465, 1985.
10. Townsend CM, Beauchamp RD, Singh P, Thompson JC: Growth factors and intestinal neoplasms. Am J Surg 155: 525-536, 1989.
11. Harrison JD, Watson SA, Morris DL: The effect of sex hormones a tamoxifen on the growth of human gastric and colorectal cancer cell lines. Cancer 63: 2148-2151, 1989.
12. Meggouh F, Lointier P, Pezet D, Saez S: Status of steroid hormon receptors in large bowel cancer. Cancer 67: 1964-1970, 1991.
13. Wu N, Cai X, Wu L: Determination of estrogen receptor in human colon cancer tissue with labelled fluorescence estradiol. Chin Med J 94: 607-610, 1981.
14. Odagiri E, Jibiki K, Demura R, Shinozaki H, Nakamura S, Demuri Suzuki H: Steroid receptors and the distribution of IR-carcinoembryonic antigen in colon cancer. Dis Colon Rectum 27: 787-791, 1984.
15. Sica V, Nola E, Contieri E, Bova R, Massuci MT, Medici N, Petrillo A, Weisz A, Molinari AM, Puca GA: Estradiol and progesterone receptors in malignant gastrointestinal tumors. Cancer Res 44: 4670-4674, 1984.
16. Murakami H, Masui H: Hormonal control of human colon carcinoma cell growth in serum-free medium. Proc Natl Acad Sci 77: 3464-3468,1980.
17. Huschtscha L, Rozengurt E, Bodmer FW: Growth factor requirement of human colorectal tumor cells:Relations to cellular differentiation. Eur J Cancer 27: 1680-1684, 1991.
18. Corman LM: Carcinoma of the colon, carcinoma of the rectum. In: Corman LM (editor). Colon and rectal surgery, pp 487-721. Philadelphia: J. B. Lippincott Company, 1993.